• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Bayer AG ADR

Bayer AG ADR

Bayer AG ADR BAYRY 3 Star

Last Price$147.17Day Change (%)0.80%
Open Price$145.96Day Change ($)1.17
Day Range145.06–147.2552-Week Range2.14–156.77

As of Fri 4/24/2015 4:59:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Research and Markets: Global Veterinary Feed Additives Market Analysis & Forecast Report 2014-2020

    Research and Markets: Global Veterinary Feed Additives Market Analysis & Forecast Report 2014-2020

  2. KILL HP Uses BrandMaker MRM Software to Implement Its Global Marketing Portal, the “Co-Marketing Zone”

    KILL HP Uses BrandMaker MRM Software to Implement Its Global Marketing Portal, the “Co-Marketing Zone”

  3. Research and Markets: Global Bioplastic Packaging Material Market 2015-2019 - Bio-PET, PLA and PLA Blends, Starch Blends, Bio-PE, and Others

    Research and Markets: Global Bioplastic Packaging Material Market 2015-2019 - Bio-PET, PLA and PLA Blends, Starch Blends, Bio-PE, and Others

  4. Research and Markets: MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")

    Research and Markets: MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")

  5. Bayer's CEO Injects a Dose of U.S. Risk-Taking

    Bayer's CEO Injects a Dose of U.S. Risk-Taking

  6. At Bayer , A Dose Of US Risk-Taking

    At Bayer , A Dose Of US Risk-Taking

  7. Research and Markets: ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015

    Research and Markets: ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015

  8. Research and Markets: Kidney Cancer Drugs (Afinitor, Avastin, Inlyta, Nexavar, Proleukin, Sutent, Torisel, Votrient) Market - Global Industry Analysis 2014-2020

    Research and Markets: Kidney Cancer Drugs (Afinitor, Avastin, Inlyta, Nexavar, Proleukin, Sutent, Torisel, Votrient) Market - Global Industry Analysis 2014-2020

  9. Cellectis Plant Sciences, Inc. Locks Early CRISPR Intellectual Property Uses in Plants

    Cellectis Plant Sciences, Inc. Locks Early CRISPR Intellectual Property Uses in Plants

  10. Cellectis Plant Sciences, Inc. Publishes a Study Demonstrating Reduced Acrylamide in Fried Potatoes

    Cellectis Plant Sciences, Inc. Publishes a Study Demonstrating Reduced Acrylamide in Fried Potatoes

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.